Alkermes
ALKS
#2552
Rank
$7.00 B
Marketcap
$41.75
Share price
2.98%
Change (1 day)
33.56%
Change (1 year)

Number of shares outstanding for Alkermes (ALKS)

Number of shares outstanding as of October 2026 : 167,026,000

According to Alkermes's latest financial reports and stock price the company's current number of shares outstanding is 167,026,000. At the end of 2026 the company had 167,026,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alkermes from 2000 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.16 B1.02%
20250.16 B2.09%
20240.16 B-2.96%
20230.16 B1.56%
20220.16 B1.55%
20210.16 B1.68%
20200.15 B0.95%
20190.15 B1.5%
20180.15 B0.95%
20170.15 B1.13%
20160.15 B1.21%
20150.15 B2.35%
20140.14 B7.92%
20130.13 B3.03%
20120.13 B1.87%
20110.12 B35.54%
201095.66 M0.93%
200994.78 M-0.56%
200895.31 M-6.28%
20070.10 B0.8%
20060.10 B10.26%
200591.5 M1.47%
200490.17 M1.31%
200389.01 M38.2%
200264.4 M0.8%
200163.89 M14.78%
200055.67 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Johnson & Johnson
JNJ
2,408,228,000 1,341.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
1,905,000,000 1,040.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
5,699,000,000 3,312.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,393,200,000 1,332.83%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2,042,000,000 1,122.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
1,551,000,000 828.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
55,340,700-66.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
1,242,000-99.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,165,000,000 597.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel